When a hospital in Riyadh, a health ministry in Nairobi, or a distributor in Karachi imports medicines from a UK wholesaler, the quality of those medicines does not depend solely on the manufacturer. It depends on every hand that touches them between the factory and the patient. Good Distribution Practice — GDP — is the regulatory framework that governs this entire chain, and understanding it is essential for any procurement team sourcing pharmaceuticals internationally.
This guide explains what GDP means in practical terms, how the UK's MHRA enforces it, what a GDP-compliant supply chain looks like, and what international buyers should check when evaluating a UK wholesale supplier.
What Is Good Distribution Practice?
GDP is a quality system for the wholesale distribution of medicinal products. It covers every activity involved in obtaining, holding, supplying, and exporting pharmaceutical products, from the point where the medicine leaves the manufacturer to the point where it reaches the dispensing pharmacy, hospital, or end user.
The objective is straightforward: to ensure that the quality of a medicinal product is maintained throughout the distribution chain. A medicine that was manufactured to the highest GMP standards becomes worthless — or dangerous — if it is subsequently stored at the wrong temperature, exposed to contamination, or loses its traceability. GDP exists to prevent this.
In the UK, GDP requirements are set out in the EU Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 343/01), which the UK retained in its regulatory framework post-Brexit. The MHRA is the competent authority responsible for enforcing these guidelines.
GDP vs GMP: GMP (Good Manufacturing Practice) governs how medicines are made. GDP governs how they are distributed after manufacture. Both are essential, and both are enforced by the MHRA in the UK. A fully compliant supply chain requires both GMP-certified manufacturers and GDP-compliant distributors.
The Nine Chapters of GDP
The GDP guidelines are structured into nine chapters, each covering a specific aspect of pharmaceutical distribution. Understanding these chapters gives importers a clear picture of what a compliant UK wholesaler should have in place.
Chapter 1: Quality Management
Every WDA holder must operate a documented quality management system covering all distribution activities. This includes a quality manual, standard operating procedures (SOPs), a system for handling deviations and complaints, regular self-inspections, and management reviews. The quality system must be overseen by a designated Responsible Person (RP) — a named individual who is legally responsible for ensuring GDP compliance.
Chapter 2: Personnel
GDP requires that all personnel involved in distribution activities are appropriately trained and their competence is assessed regularly. This includes training on GDP requirements, product handling, hygiene, temperature management, and the specific SOPs relevant to their role. Training records must be maintained and available for inspection.
Chapter 3: Premises and Equipment
Pharmaceutical warehouses must be designed to maintain the quality of stored products. This means appropriate temperature control (with mapping and continuous monitoring), protection from contamination, adequate security, segregated areas for quarantined, rejected and returned products, and equipment that is calibrated and maintained to documented schedules.
Chapter 4: Documentation
GDP requires comprehensive documentation of all distribution activities. This includes purchase and sales records, batch traceability, temperature monitoring records, deviation reports, supplier and customer qualification records, and delivery documentation. The underlying principle is that any product should be traceable from manufacturer to customer and back again.
Chapter 5: Operations
Operational procedures must ensure that the right product is delivered to the right customer in the right condition. This covers order processing, picking and packing, delivery, and returns handling. GDP also requires supplier qualification — a wholesaler must verify that its suppliers are authorised and that products are sourced only through the legitimate supply chain.
Chapter 6: Complaints, Returns, Suspected Falsified Products and Recalls
GDP mandates documented procedures for handling complaints, processing returns, identifying suspected falsified (counterfeit) medicines, and executing product recalls. The ability to trace every batch of every product to every customer is critical for an effective recall process.
Chapter 7: Outsourced Activities
Where a wholesaler outsources any distribution activity — such as transport, storage, or customs brokerage — the outsourced provider must meet GDP requirements. The WDA holder remains responsible for the quality of outsourced activities and must have contracts and quality agreements in place with each outsourced provider.
Chapter 8: Self-Inspections
GDP requires regular self-inspections to verify ongoing compliance. Self-inspections must cover all aspects of GDP, be conducted by competent personnel, and result in documented findings and corrective actions where necessary.
Chapter 9: Transportation
The transport chapter covers the specific requirements for moving pharmaceutical products between locations. This includes temperature-controlled transport for cold chain products, protection from breakage and contamination, validated packaging systems, and documentation of the chain of custody from point of dispatch to point of delivery.
How the MHRA Enforces GDP
The MHRA is the UK competent authority for GDP enforcement. Any company that wishes to engage in the wholesale distribution of medicinal products in the UK must hold a WDA — Wholesale Dealer Authorisation — issued by the MHRA. The WDA number for Euro Biom is WDA(H) 59239.
GDP compliance is verified through MHRA inspections. These inspections assess the wholesaler's premises, equipment, personnel, documentation, quality systems, and operational practices against the GDP guidelines. Inspections may be routine (typically every 2 to 3 years for standard risk WDA holders), triggered (in response to complaints, adverse events, or intelligence), or pre-approval (for new WDA applications).
Non-compliance identified during an inspection results in a deficiency report. Critical deficiencies must be addressed immediately and may lead to licence suspension. Major and minor deficiencies require corrective action within defined timescales. Persistent non-compliance can result in licence revocation.
| Deficiency Level | Definition | Typical Response |
|---|---|---|
| Critical | A practice or omission that has produced, or risks producing, a product harmful to the patient | Immediate corrective action; potential licence suspension |
| Major | A significant departure from GDP that risks product quality but has not yet caused patient harm | Corrective action within 28 days; follow-up inspection may be required |
| Minor | A departure from GDP that is unlikely to affect product quality but should be corrected | Corrective action within agreed timescale |
Documentation a GDP-Compliant Supplier Provides
For international buyers, the documentation that accompanies an order is a tangible measure of a supplier's GDP compliance. A UK wholesaler operating to GDP standards should provide the following with every export shipment:
| Document | Purpose |
|---|---|
| Commercial Invoice | Order details, pricing, and payment terms for customs clearance |
| Packing List | Detailed listing of products, quantities, batch numbers, and expiry dates |
| Certificate of Pharmaceutical Product (CPP) | Confirms the product's regulatory status in the UK, issued per WHO format |
| Certificate of Analysis (CoA) | Manufacturer's testing results confirming the batch meets specification |
| GMP Certificate | Confirms the manufacturer operates under GMP standards |
| Temperature Data Logger Report | Continuous temperature record for cold chain products during transit |
| Export Certificate | Confirms the shipment is authorised for export from the UK |
If a UK supplier cannot provide this documentation — or charges extra for standard documents like the CPP or CoA — that is a red flag. GDP-compliant supply includes comprehensive documentation as standard, not as an optional add-on.
Why GDP Matters for International Procurement
For procurement teams sourcing medicines from abroad, GDP compliance serves three practical purposes.
Product quality assurance. GDP-compliant storage and transport means the medicines you receive have been handled correctly throughout the supply chain. Temperature records prove the cold chain was maintained. Batch documentation proves the product is genuine and traceable to the manufacturer. Without GDP, there is no reliable way to verify that the medicine in the box is the same quality as the medicine that left the factory.
Regulatory acceptance. Most national regulators require that imported medicines come from GDP-compliant sources. When a hospital in Saudi Arabia imports through a WDA-licensed UK supplier, the SFDA recognises the regulatory oversight behind that product. When a Kenyan hospital imports from a random unlicensed source, the PPB has no basis for confidence in the product's integrity. GDP compliance is not just a quality measure — it is a regulatory requirement for market access in most countries.
Supply chain integrity. GDP requires full traceability and supplier qualification, which means products enter the supply chain only through authorised channels. This is a critical protection against falsified (counterfeit) medicines, which remain a serious global health threat. The WHO estimates that in low- and middle-income countries, up to 1 in 10 medical products is substandard or falsified. Sourcing from GDP-compliant suppliers is one of the most effective defences against this risk.
How to Verify a UK Supplier's GDP Compliance
International buyers should take the following steps to verify that a UK pharmaceutical supplier meets GDP standards before placing an order:
- Check the MHRA database: Search for the company on the MHRA's online register of wholesale dealers. Verify the WDA number, the scope of the authorisation (which product categories it covers), and that the licence is current.
- Request the GDP certificate: Ask for a copy of the most recent GDP certificate or inspection outcome. A reputable supplier will share this readily.
- Verify the Responsible Person: GDP requires every WDA holder to have a named Responsible Person (RP) who oversees compliance. Ask who the RP is and confirm their role.
- Assess documentation quality: Place a small trial order and evaluate the documentation provided. Are batch numbers, expiry dates, CoAs, and temperature records included as standard?
- Ask about insurance: GDP-compliant suppliers should carry appropriate product liability and goods-in-transit insurance.
Euro Biom holds MHRA WDA(H) 59239, operates from a GDP-compliant facility near London Heathrow, and provides full documentation with every export order. Our Responsible Person oversees all distribution activities in accordance with GDP guidelines.
Frequently Asked Questions
What is GDP in pharmaceutical distribution?
GDP (Good Distribution Practice) is the quality standard governing how pharmaceutical products are stored, transported, and documented throughout the supply chain. It is enforced in the UK by the MHRA and is a condition of holding a WDA licence.
What is a WDA licence?
A WDA (Wholesale Dealer Authorisation) is the MHRA-issued licence that permits a company to wholesale medicinal products in the UK. It confirms that the company's premises, systems, and operations meet GDP requirements.
How often does the MHRA inspect WDA holders?
Routine inspections typically occur every 2 to 3 years, though higher-risk operations may be inspected more frequently. The MHRA can also conduct triggered inspections at any time in response to complaints or intelligence.
What documents should a GDP-compliant supplier provide?
A GDP-compliant UK supplier should provide commercial invoices, packing lists, CPP (Certificate of Pharmaceutical Product), CoA (Certificate of Analysis), GMP certificates, temperature data logger reports for cold chain products, and export certificates. This documentation should be included as standard with every shipment.
How can I check if a UK supplier has a valid WDA?
You can search the MHRA online database of wholesale dealer licences to verify any UK supplier's WDA status, licence number, and scope of authorisation.
Source from a GDP-Compliant UK Supplier
Euro Biom holds MHRA WDA(H) 59239 and provides full GDP-compliant documentation with every export order. Tell us what you need.
Submit an Enquiry →